Company intelligence / Profile preview

Sino-Swed Pharmaceutical Co., Ltd.

Wuxi City, Jiangsu Province, China

Ownership: Private
Employees: ~840
Development stage: Commercial

Overview

Sino-Swed Pharmaceutical Co., Ltd. (SSPC) is a major Chinese pharmaceutical joint venture specializing in the production of infusion solutions for clinical nutrition. The company is recognized as a market leader in this segment within China, with high-quality manufacturing standards and significant market share. As of 2004, it had approximately 840 employees and annual revenue of about €56 million, with its Wuxi plant noted for advanced quality standards[7].

Therapeutic areas: Gastroenterology
Modalities: Infusion solutions for clinical nutrition[7]
Industry: Biotech

Partnerships

Sinopharm Group Co., Ltd.[5][1][4]Fresenius Kabi AG (historical joint venture partner)[7]

Beyond the preview

Go deeper on Sino-Swed Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sino-Swed Pharmaceutical Co., Ltd..

Explore the full profile